help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Journal of Clinical Endocrinology & Metabolism, doi:10.1210/jc.2008-0251
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Data
Right arrow All Versions of this Article:
93/7/2566    most recent
Author Manuscript (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Google Scholar
Right arrow Articles by Rossi, G. P.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rossi, G. P.
Related Collections
Right arrow Adrenal and Hypertension
Right arrow Cardiovascular Endocrinology
Right arrow Obesity
The Journal of Clinical Endocrinology & Metabolism Vol. 93, No. 7 2566-2571
Copyright © 2008 by The Endocrine Society

Body Mass Index Predicts Plasma Aldosterone Concentrations in Overweight-Obese Primary Hypertensive Patients

Gian Paolo Rossi, Anna Belfiore, Giampaolo Bernini, Bruno Fabris, Graziella Caridi, Claudio Ferri, Gilberta Giacchetti, Claudio Letizia, Mauro Maccario, Massimo Mannelli, Gaetana Palumbo, Anna Patalano, Damiano Rizzoni, Ermanno Rossi, Achille C. Pessina, Franco Mantero the Primary Aldosteronism Prevalence in hYpertension Study Investigators1

DMCS Internal Medicine 4 (G.P.R., A.C.P.) and Endocrinology (F.M., A.P.), Azienda Ospedale Università, 35126 Padova Italy; Endocrinology (G.G., V.R., M.B.), Ospedale Umberto I, 60100 Ancona, Italy; Internal Medicine (E.R.), Azienda Ospedaliera ASMN, 42100 Reggio Emilia, Italy; Internal Medicine (G.B., A.M.), Ospedale Santa Chiara, 56100 Pisa, Italy; Department of Internal Medicine and Public Health (C.F., G.D.), University of L’Aquila, 67100 L’Aquila, Italy; Internal Medicine (G.A., G.C.), Policlinico Universitario, 90127 Palermo, Italy; Internal Medicine (D.R., E.P., E.A.-R.), Spedali Civili EULO, 25123 Brescia, Italy; Internal Medicine (G.P., C.C., M.T.L.), Ospedale Civile, 20025 Legnano, Italy; Internal Medicine, Department of Clinical Sciences (C.L., C.C.), University "La Sapienza", 00165 Roma, Italy; Internal Medicine (B.F.), Ospedale "Cattinara", 34121 Trieste, Italy; Endocrinology (M.M., G.P.), Azienda Ospedaliera "Careggi", 50139 Firenze, Italy; Endocrinology (M.M., E.G.), Ospedale "Molinette", 10126 Torino, Italy; Nephrology (F.M., G.C., C.Z.), Ospedale di Reggio Calabria, 89131 Reggio Calabria, Italy; and Internal Medicine (A.B.), Azienda Ospedaliera Policlinico, 70124 Bari, Italy

Address all correspondence and requests for reprints to: Professor Gian Paolo Rossi, M.D., F.A.C.C., F.A.H.A., DMCS-Clinica Medica 4, University Hospital, via Giustiniani, 2, 35126 Padova, Italy. E-mail: gianpaolo.rossi{at}unipd.it.

Context: Body mass index (BMI) shows a direct correlation with plasma aldosterone concentration (PAC) and urinary aldosterone excretion in normotensive individuals; whether the same applies to hypertensive patients is unknown.

Objective: Our objective was to determine if BMI predicts PAC and the PAC/plasma renin activity ratio [aldosterone renin ratio (ARR)] in hypertensive patients, and if this affects the identification of primary aldosteronism (PA).

Design: This was a prospective evaluation of consecutive hypertensive patients referred nationwide to specialized hypertension centers.

Main Outcome Measures: Sitting PAC, plasma renin activity, and the ARR, baseline and after 50 mg captopril orally with concomitant assessment of parameters, including BMI and daily sodium intake, were calculated.

Results: Complete biochemical data and a definite diagnosis were obtained in 1125 consecutive patients. Of them 999 had primary (essential) hypertension (PH) and 126 (11.2%) PA caused by an aldosterone-producing adenoma in 54 (4.8%). BMI independently predicted PAC (β = 0.153; P < 0.0001) in PH, particularly in the overweight-obese, but not in the PA group. Covariance analysis and formal comparison of the raw, and the BMI-, sex-, and sodium intake-adjusted ARR with receiver operator characteristic curves, showed no significant improvement for the discrimination of aldosterone-producing adenoma from PH patients with covariate-adjusted ARR.

Conclusions: BMI correlated with PAC independent of age, sex, and sodium intake in PH, but not in PA patients. This association of BMI is particularly evident in overweight-obese PH patients, and suggests a pathophysiological link between visceral adiposity and aldosterone secretion. However, it does not impact on the diagnostic accuracy of the ARR for discriminating PA from PH patients.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2008 by The Endocrine Society